Batch Records for Medical Devices: Complete Guide to BMR, EBR, and DHR — Paper vs Electronic, 21 CFR 210/211 Compliance, and FDA QMSR Requirements

The Document That Can Make or Break Your FDA Inspection

In fiscal year 2025, more than one-third of FDA warning letters cited GMP violations tied to documentation failures — missing signatures, incomplete batch records, and inconsistent procedures. CDER warning letters jumped 50% year-over-year, with batch record deficiencies appearing in 42% of pharmaceutical facility inspections between 2020 and 2023. Manual data entry causes 30-40% of all batch record deviations in facilities still reliant on paper.

The batch record is often the first document an FDA inspector asks to see. It is the legal evidence that a product was manufactured according to approved procedures, under controlled conditions, with every material, measurement, and operator documented. Without accurate batch records, a manufacturer cannot prove compliance, trace problems, or release product.

This guide covers every aspect of batch records for medical device and combination product manufacturing — from the regulatory framework (21 CFR Parts 210, 211, and 820/QMSR) to the practical differences between paper and electronic systems, the review process, deviation management, and implementation best practices.

What Is a Batch Record?

Definitions

A batch record is the complete, contemporaneous documentation for a specific batch of product. It captures every manufacturing, packaging, cleaning, and testing step — who did it, when it happened, which materials were used, and the results obtained.

The FDA defines a batch (or lot) as "one or more components or finished devices that consist of a single type, model, class, size, composition, or software version that are manufactured under essentially the same conditions and are intended to have uniform characteristics and quality within specified limits."

Types of Manufacturing Records

Understanding the record taxonomy is essential for compliance:

Record Type	Abbreviation	Definition	Purpose	Regulatory Basis
Master Batch Record	MBR/MBR	Pre-approved template outlining the manufacturing process, materials, and controls	Ensures every batch is made consistently according to GMP	21 CFR 211.186 (drugs); ISO 13485 Clause 7.5.1 (devices)
Batch Manufacturing Record	BMR	Completed documentation of actual batch execution against the MBR	Proof that the batch followed approved procedures	21 CFR 211.188
Batch Production Record	BPR	Captures actual production data for each batch — quantities, conditions, deviations	Detailed record of what actually happened during production	21 CFR 211.188
Packaging Batch Record	PBR	Documents final packaging and labeling operations	Ensures correct packaging and labeling	21 CFR 211.188
Electronic Batch Record	EBR/eBR	Digital version of batch records with automated workflows and controls	Reduces errors, enforces sequencing, provides real-time QA visibility	21 CFR Part 11, EU GMP Annex 11
Device History Record	DHR	Records all activities for a specific device unit or batch	Required under 21 CFR 820.184 for medical devices	21 CFR Part 820 (QMSR)
Electronic Device History Record	eDHR	Digital DHR with automated data capture	Improves traceability, reduces paper burden	21 CFR Part 11, ISO 13485

The Manufacturing Record Stack

Think of these records as a layered system:

1. MBR — The approved recipe and process instructions
2. BMR — The proof that the recipe was followed for a specific batch
3. EBR — The digital enforcement and capture layer for the BMR
4. DHR/eDHR — The complete historical record for device-level traceability (medical devices specifically)

If the MBR is the recipe, the BMR is the proof it was followed, and the EBR makes sure nothing is missed during execution.

Regulatory Framework

21 CFR Parts 210 and 211 (Drugs and Combination Products)

For pharmaceutical and combination product manufacturing, batch record requirements are explicit:

21 CFR 211.186 — Master Production and Control Records: Requires a written master production and control record for each product, including the formula, step-by-step manufacturing instructions, sampling, and control procedures. Must be drafted, reviewed, and signed off by the quality unit.

21 CFR 211.188 — Batch Production and Control Records: Requires batch production and control records for each batch, including:

• Accurate reproduction of the master record, checked and signed
• Dates of each significant manufacturing step
• Identity of individual major equipment and lines used
• Specific identification of each batch of component or in-process material used
• Weights and measures of components used
• In-process and laboratory control results
• Inspection of packaging and labeling areas before and after use
• Actual yield and percentage of theoretical yield at appropriate phases
• Complete labeling control records
• Description of drug product containers and closures
• Any sampling performed
• Identification of persons performing and supervising each significant step
• Any investigation made per 21 CFR 211.192
• Results of examinations per 21 CFR 211.134

21 CFR 211.192 — Batch Record Review: Requires the quality control unit to review and approve all batch records, including packaging and labeling, before release. Any discrepancy or failure must be investigated, whether or not the batch has been distributed.

21 CFR Part 820 / QMSR (Medical Devices)

For medical device manufacturing, the QMSR (effective February 2, 2026) requires:

Device History Record (DHR) per 21 CFR 820.184 must include:

• Dates of manufacture
• Quantity manufactured
• Quantity released for distribution
• Acceptance records demonstrating the device was manufactured in accordance with the DMR (Device Master Record)
• Primary identification label and labeling used for each production unit
• Any UDI or universal product code, and any other device identification(s) and control number(s) used

Under the QMSR, which incorporates ISO 13485:2016 by reference, additional requirements include:

• Production records demonstrating processes were carried out under controlled conditions (Clause 7.5.1)
• Traceability records for product, components, and materials (Clause 7.5.9)
• For implantable devices, records of all components and work environment conditions
• Records of sterilization processes, traceable to specific lots/batches

21 CFR Part 11 (Electronic Records)

Electronic batch records must comply with 21 CFR Part 11, which defines criteria under which electronic records and electronic signatures are equivalent to paper records and handwritten signatures. Key requirements:

Part 11 Requirement	What It Means for EBR Systems
System validation	EBR systems must be validated to ensure accuracy, reliability, and consistent performance
Audit trail	All changes to electronic records must be tracked with before-and-after values, timestamp, and user identity
Electronic signatures	Must be unique to one individual, not shared, and include printed name, date/time, and meaning (e.g., "review," "approval")
Access controls	Role-based access limiting who can create, modify, or approve records
Record retention	Electronic records must be retrievable for the required retention period
Authority checks	System must enforce that only authorized personnel can sign or approve

EU GMP Annex 11

For companies manufacturing in or exporting to the EU, Annex 11 sets additional requirements for computerized systems:

• Risk-based validation approach proportional to the system's impact on product quality
• Data must be backed up and recoverable
• Audit trails must be retained for the system lifecycle
• Systems must maintain data integrity throughout the retention period
• Electronic signatures must be linked to their respective records

Recommended Reading

Equipment Calibration Management for Medical Devices: ISO 13485 Clause 7.6 Complete Guide

Quality Systems ISO 134852026-04-17 · 21 min read

Paper Batch Records vs Electronic Batch Records

Side-by-Side Comparison

Dimension	Paper BMR	Electronic Batch Record (EBR)
Data entry	Manual — 30-40% deviation rate from entry errors	Automated data capture, real-time validation, reduced errors
Review speed	Days to weeks for QA review	Hours — automated checks flag issues immediately
Audit trail	Physical signatures, carbon copies, paper trails	System-generated, tamper-proof, ALCOA+ compliant
Deviation tracking	Paper forms, manual routing	Automated deviation capture, workflow-based routing
Retrieval	Physical storage, manual search	Instant search and retrieval, indexed records
Compliance risk	Higher — missing signatures, incomplete forms, backdating	Lower — enforced completion, mandatory fields, timestamping
Scalability	Linear cost increase with volume	Flat or decreasing per-batch cost at scale
Regulatory readiness	Weeks of preparation for inspections	Real-time compliance visibility, instant access
Cost structure	Low upfront, high ongoing labor and storage	Higher upfront (software, validation), lower ongoing cost
Data integrity	Relies on personnel discipline (ALCOA principles)	System-enforced ALCOA+ — attributable, legible, contemporaneous, original, accurate, complete, consistent, enduring, available
Signature management	Physical wet-ink signatures	Electronic signatures per 21 CFR Part 11
Version control	Manual — risk of using outdated forms	Automated — only current approved version accessible

Market Shift Toward Electronic Systems

The global EBR market was valued at $1.28 billion in 2025 and is projected to reach $9.62 billion by 2040 at a CAGR of 14.4%. This growth is driven by regulatory pressure for data integrity, demand for real-time manufacturing visibility, and measurable efficiency gains. Facilities implementing EBR systems report batch release times reduced by 40% and audit findings reduced by 60-75%.

When Paper Still Makes Sense

EBR is not mandatory — paper batch records remain acceptable if they meet cGMP requirements. Paper may be appropriate for:

• Small manufacturers with low production volumes
• Products with simple, stable manufacturing processes
• Companies in early-stage operations before investing in electronic systems
• Situations where electronic system validation is impractical

However, the regulatory trend is clear: inspectors increasingly expect electronic systems, and paper-based facilities face higher scrutiny during inspections.

Building a Batch Record: What Must Be Included

Required Content for a Drug/Combination Product BMR

Every batch manufacturing record for drugs or combination products must contain:

Section	Required Elements
Header information	Product name, strength, batch/lot number, batch size, date of manufacture
Master record reference	Accurate reproduction of the current approved master production record
Materials	List of all components with lot numbers, quantities, weigh-in records, supplier CoA references
Equipment	Identity of all major equipment and lines used, including equipment logs
Process steps	Chronological documentation of each significant manufacturing step with dates and times
In-process controls	All in-process test results, environmental monitoring, parameter recording
Yield reconciliation	Actual yield vs. theoretical yield at each critical phase
Labeling	Complete labeling control records, including specimens or copies of all labeling used
Packaging	Description of containers and closures, packaging line clearance
Signatures	Identification of persons performing and directly supervising each significant step
Deviations	Any deviations from the master record, with investigation references
Laboratory results	All laboratory control results and finished product testing
Investigations	Any investigation conducted per 21 CFR 211.192

Required Content for a Medical Device DHR

Every device history record must contain:

Section	Required Elements
Header	Device name, model/catalog number, lot/batch/serial number, date(s) of manufacture
Quantity	Quantity manufactured and quantity released for distribution
Acceptance records	Documentation that the device was manufactured in accordance with the DMR — inspection results, test data, verification records
Labeling	Primary identification label and labeling used for each production unit
UDI	Any UDI, UPC, and other device identification and control numbers used
Traceability	Component lot numbers, material certifications, supplier traceability
Process records	Evidence of process controls — equipment used, parameters recorded, environmental conditions
Nonconformances	Any nonconforming material or process deviations with disposition
Release	Final QA/QC review and release signature

The Batch Record Review Process

Three-Tier Review Model

Best-practice batch record review follows a tiered approach:

Tier 1 — Production Operator Self-Review (at time of completion):

• All fields completed — no blanks (use N/A where appropriate)
• All entries in indelible ink (paper) or system-validated fields (electronic)
• All attachments included
• Calculations verified
• Signatures and dates present at each step
• Deviations noted and flagged

Tier 2 — Production Supervision Review (within 24-48 hours):

• Yields fall within acceptable ranges
• Process deviations reviewed and properly documented
• Procedural compliance verified throughout manufacturing
• Equipment logs match batch record entries
• Material reconciliation acceptable

Tier 3 — Quality Unit Review (before batch release):

• Critical quality attribute results meet specifications
• Impact of any deviations on product quality evaluated
• All investigations completed and referenced
• Labeling accuracy verified
• Batch meets all acceptance criteria
• Approval or rejection decision documented

This tiered approach catches different error types at appropriate levels — production staff spot execution problems while quality reviewers focus on compliance and product specifications.

Common Review Findings

The most frequent issues QA reviewers find in batch records:

1. Missing data — Blank fields, incomplete entries, skipped steps
2. Missing signatures — Steps completed without contemporaneous sign-off
3. Calculation errors — Incorrect yield calculations, transposition errors
4. Backdating — Entries made after the fact rather than at time of activity
5. Unauthorized corrections — White-out used, overwritten entries, corrections without explanation
6. Out-of-specification results — Not flagged, not investigated
7. Inconsistent information — Discrepancies between batch record and equipment logs
8. Missing attachments — Certificates of analysis, strip chart recordings, printouts not attached
9. Labeling errors — Wrong label version, incorrect lot number on labels
10. Incomplete investigations — Deviations noted but root cause investigation not completed before release

Proper Correction Methods (Paper Records)

For paper batch records, corrections must follow cGMP data integrity principles:

• Draw a single line through the error (do not obscure the original entry)
• Write the correct value nearby
• Initial and date the correction
• Provide a brief reason for the correction

Never use white-out, erasures, or overwriting. These are immediate red flags during FDA inspections.

Recommended Reading

CSV to CSA Transition: Complete Guide to FDA's 2025 Computer Software Assurance Final Guidance

Quality Systems FDA QMSR2026-04-17 · 17 min read

Deviation Management in Batch Records

Types of Deviations

Deviation Type	Definition	Example
Planned deviation	Pre-approved departure from standard procedure	Using an alternative raw material supplier due to shortage
Unplanned deviation	Unexpected departure from standard procedure	Equipment malfunction during manufacturing
In-process deviation	Parameter outside specified range during production	Temperature excursion during mixing
Documentation deviation	Error in how the batch record was completed	Missing signature, incorrect date entry

Deviation Handling Process

1. Identify: Deviation is detected during manufacturing or review
2. Document: Record the deviation in the batch record with full details
3. Evaluate: Assess impact on product quality — is the batch still within specification?
4. Investigate: Determine root cause (may require full CAPA investigation)
5. Dispo: Make batch disposition decision — release, rework, or reject
6. CAPA: If systemic, initiate corrective and preventive action
7. Trend: Track deviations over time to identify recurring issues

Deviation Impact Assessment Matrix

Impact Level	Criteria	Batch Disposition	Required Actions
Minor	No impact on critical quality attributes	May be released	Document deviation, evaluate for trending
Major	Potential impact on product quality	Hold pending investigation	Full root cause analysis, may require CAPA
Critical	Confirmed impact on safety or efficacy	Reject or hold	Immediate CAPA, potential field action, regulatory notification

Implementing Electronic Batch Records

EBR System Requirements

An EBR system must satisfy these regulatory and functional requirements:

Category	Requirements
Regulatory compliance	21 CFR Part 11 (electronic records/signatures), EU GMP Annex 11, ISO 13485 Clause 7.5
Data integrity	ALCOA+ principles — attributable, legible, contemporaneous, original, accurate, complete, consistent, enduring, available
Audit trail	All changes captured with before/after values, timestamp, user, reason
Access control	Role-based permissions — operators, supervisors, QA, administrators
Electronic signatures	Unique per user, meaning-coded (execution, review, approval), timestamped
Workflow enforcement	Sequential step execution — cannot skip steps or proceed without completion
Integration	Connects to ERP, MES, LIMS, QMS systems for data flow
Validation	IQ/OQ/PQ validation, user acceptance testing, periodic review
Reporting	Real-time dashboards, batch status tracking, deviation trending
Retention	Records retrievable for required retention period (device lifetime, minimum 2 years)

EBR Implementation Roadmap

Phase	Timeline	Activities
1. Assessment	Months 1-2	Inventory current paper processes, define EBR scope, select software vendor, establish project team
2. Configuration	Months 2-4	Configure master batch record templates, define workflows, set up role-based access, establish integration points
3. Validation	Months 4-6	IQ/OQ/PQ protocols, user acceptance testing, Part 11 compliance verification, data migration testing
4. Training	Months 5-6	Operator training on EBR system, supervisor training on review workflows, QA training on electronic review
5. Pilot	Months 6-7	Run parallel production with paper and electronic records, validate data accuracy, gather user feedback
6. Go-live	Month 7+	Full EBR deployment, retire paper records, ongoing monitoring and optimization

Transition Challenges

Moving from paper to electronic batch records introduces challenges that go beyond a software swap:

• Process redesign: Paper-based workflows rarely translate directly to electronic systems. Every workflow must be analyzed and redesigned.
• Change management: Operators accustomed to paper may resist electronic systems. Training and communication are essential.
• Data migration: Historical paper records must remain accessible while new electronic records are established.
• Validation burden: EBR systems require formal validation (IQ/OQ/PQ) — this is a significant project in itself.
• Hybrid period: During transition, companies may operate both paper and electronic systems simultaneously, creating compliance risks if not carefully managed.

A poorly implemented EBR introduces its own data integrity risks. Shared login credentials, inadequate access controls, and missing audit trail configuration are common findings during inspections at facilities that transitioned without proper validation.

Batch Records in the Medical Device Context

DHR vs BMR: Key Differences

Aspect	BMR (Drug/Pharma)	DHR (Medical Device)
Regulatory basis	21 CFR 211.188	21 CFR 820.184 (QMSR), ISO 13485
Scope	Batch-level documentation	Unit or batch-level documentation
Required content	Detailed process steps, yields, laboratory results	Acceptance records, labeling, UDI, quantities
Release mechanism	QA review and approval per 21 CFR 211.192	QA review demonstrating DMR compliance
Traceability	Component lots, process parameters	Component lots, device identification, UDI
Retention	1 year after expiration or 3 years after distribution	Device lifetime, minimum 2 years from release
Electronic equivalent	EBR (Electronic Batch Record)	eDHR (Electronic Device History Record)

When Both Apply: Combination Products

Combination products (drug-device or biologic-device) must comply with both sets of requirements. 21 CFR Part 4 provides a streamlined cGMP framework allowing manufacturers to implement a single quality system that satisfies both drug (21 CFR Parts 210/211) and device (21 CFR Part 820/QMSR) requirements, with demonstrated compliance in both areas.

Recommended Reading

GMP vs cGMP for Medical Devices: Complete Guide to Current Good Manufacturing Practice Under FDA QMSR (21 CFR 820)

Quality Systems FDA QMSR2026-04-17 · 20 min read

Best Practices for Batch Record Compliance

For Manufacturing Teams

1. Make entries at the time of activity — never complete records after the fact
2. Use indelible ink for all paper entries
3. Complete all fields — use N/A where appropriate, never leave blank
4. Sign and date immediately after each step
5. Report deviations promptly when they occur — do not wait until end of batch
6. Perform self-review before submitting to QA
7. Verify all attachments are included
8. Check calculations independently

For QA Reviewers

1. Use standardized review checklists to prevent missing critical elements
2. Review chronologically — follow the manufacturing sequence
3. Cross-reference with equipment logs and material receipts
4. Evaluate every deviation for impact on product quality
5. Ensure investigations are complete before batch release
6. Document the review — your review is itself a regulated activity
7. Track review metrics — time to review, rejection rate, recurring findings

For Management

1. Invest in training — data integrity culture starts with understanding
2. Allocate sufficient QA resources — rushed reviews lead to missed issues
3. Implement electronic systems when volume justifies the investment
4. Monitor batch record metrics — deviation rates, review times, rejection rates
5. Conduct periodic trend analysis of batch record findings to identify systemic issues

Frequently Asked Questions

What is the difference between a Master Batch Record (MBR) and a Batch Manufacturing Record (BMR)?

The MBR is the pre-approved template that defines the manufacturing process — the recipe. It specifies materials, equipment, procedures, and acceptance criteria. The BMR is the completed record for a specific batch — the proof the recipe was followed. Every BMR is generated from the current approved MBR. If the MBR is the plan, the BMR is the execution.

Are electronic batch records required by FDA?

No. The FDA does not mandate electronic batch records. Paper batch records remain acceptable if they meet cGMP requirements. However, if you use electronic records, they must comply with 21 CFR Part 11 requirements for electronic records and electronic signatures. The regulatory trend strongly favors electronic systems due to their superior data integrity controls.

How long must batch records be retained?

For drugs: Batch records must be retained for at least 1 year after the expiration date of the batch, or 3 years after distribution for OTC products without expiration dating (21 CFR 211.180). For medical devices: Records must be retained for at least the lifetime of the device, but not less than 2 years from the date of release (ISO 13485 Clause 4.2.5, as incorporated by QMSR). Always check the longer retention period when both drug and device requirements apply.

Who can approve batch records for release?

The quality control unit (quality unit) must review and approve all batch records before batch release (21 CFR 211.192). This means a qualified QA reviewer, not the production operator or supervisor, makes the final release decision. The three-tier review model (operator self-review, supervisor review, QA review) ensures independence between production and quality.

What is the ALCOA+ principle for batch records?

ALCOA+ is a data integrity framework that applies to all batch record entries:

• Attributable — Who performed the activity and when
• Legible — Readable and permanent
• Contemporaneous — Recorded at the time of activity
• Original — The first recording of the data
• Accurate — Correct and truthful
• Complete — All data including repeat tests
• Consistent — Chronological, time/date stamps logical
• Enduring — Recorded on appropriate media
• Available — Accessible throughout retention period

What happens if a batch record has deviations?

Deviations must be documented in the batch record and evaluated for impact on product quality. The quality unit determines whether the deviation affects the batch's ability to meet specifications. Minor deviations may be released with documentation. Major or critical deviations require investigation, root cause analysis, and may trigger CAPA. The batch may be released, held for additional testing, reworked (if possible), or rejected depending on the investigation outcome.

How do batch records apply to medical device manufacturing specifically?

For medical devices, the equivalent document is the Device History Record (DHR), required under 21 CFR 820.184. The DHR documents that each device (or batch of devices) was manufactured in accordance with the Device Master Record (DMR). It includes acceptance records, labeling records, UDI information, and quantities manufactured and released. Under the QMSR (effective February 2, 2026), DHR requirements are supplemented by ISO 13485 production and traceability requirements.

Can batch records be corrected after completion?

Yes, corrections are permitted but must follow strict procedures. For paper records: draw a single line through the error, write the correct value, initial, date, and note the reason. Never use white-out or erasures. For electronic records: corrections must be made through the system's amendment function, which captures the original value, corrected value, reason, user identity, and timestamp in the audit trail.

What is the relationship between batch records and CAPA?

Batch records are a primary input to the CAPA system. Deviations, out-of-specification results, and nonconformances identified during batch record review feed into CAPA investigations. CAPA effectiveness is often verified by monitoring subsequent batch records for recurrence of the original issue. Together, batch records and CAPA form a closed-loop quality system for continuous improvement.

How much does an EBR system cost?

EBR system costs vary widely depending on company size, complexity, and vendor. For small-to-mid-size manufacturers, cloud-based eQMS solutions with EBR functionality typically range from $20,000 to $100,000 per year for subscription plus implementation costs. Enterprise MES-integrated EBR systems for large manufacturers can range from $200,000 to over $1 million including validation. The ROI typically comes from reduced QA review time (40% reduction), fewer deviations (60-75% reduction), and faster batch release.